EAM Investors’s Halozyme HALO Stock Holding History

EAM Investors’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-82,285	Closed	-$4.71M	–	296
2024 Q3	$4.71M	Buy	+82,285	New	+$4.72M	0.7%	37
2023 Q1	–	Sell	-36,732	Closed	-$2.09M	–	304
2022 Q4	$2.09M	Buy	+36,732	New	+$1.88M	0.43%	86
2022 Q3	–	Sell	-40,923	Closed	-$1.8M	–	290
2022 Q2	$1.8M	Buy	+40,923	New	+$1.77M	0.44%	85
2021 Q2	–	Sell	-36,678	Closed	-$1.53M	–	359
2021 Q1	$1.53M	Buy	36,678 +3,321	+10%	+$152K	0.23%	213
2020 Q4	$1.43M	Sell	33,357 -21,095	-39%	-$758K	0.23%	204
2020 Q3	$1.43M	Sell	54,452 -30,692	-36%	-$855K	0.34%	121
2020 Q2	$2.28M	Buy	+85,144	New	+$1.92M	0.5%	55
2015 Q3	–	Sell	-158,947	Closed	-$3.59M	–	311
2015 Q2	$3.59M	Sell	158,947 -65,437	-29%	-$1.15M	0.42%	79
2015 Q1	$3.2M	Buy	+224,384	New	+$3.24M	0.37%	136

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

EAM Investors's HALO Position: Q4 2024 in Review

EAM Investors sold out of Halozyme (HALO) in Q4 2024, closing a stake of 82,285 shares — an estimated $4.71M sold.

EAM Investors first reported a position in HALO in Q1 2015 and held it in 9 quarters. The position peaked at $4.71M in Q3 2024. 508 funds tracked by Wall St. Rank hold HALO as of Q4 2024.

EAM Investors reported no remaining Halozyme position as of Q4 2024 after selling out during the quarter.
EAM Investors sold 82,285 Halozyme shares in Q4 2024, an estimated $4.71M.
EAM Investors first reported a position in Halozyme in Q1 2015 and held it in 9 quarters.
EAM Investors's Halozyme position peaked at $4.71M in Q3 2024.
508 funds tracked by Wall St. Rank held Halozyme as of Q4 2024.

Based on EAM Investors's 13F filing for Q4 2024, filed 13 Feb 2025.